195 related articles for article (PubMed ID: 14670812)
1. Inhibition of cyclooxygenase-2 improves cardiac function after myocardial infarction in the mouse.
LaPointe MC; Mendez M; Leung A; Tao Z; Yang XP
Am J Physiol Heart Circ Physiol; 2004 Apr; 286(4):H1416-24. PubMed ID: 14670812
[TBL] [Abstract][Full Text] [Related]
2. Reduced cardiac remodeling and function in cardiac-specific EP4 receptor knockout mice with myocardial infarction.
Qian JY; Harding P; Liu Y; Shesely E; Yang XP; LaPointe MC
Hypertension; 2008 Feb; 51(2):560-6. PubMed ID: 18180401
[TBL] [Abstract][Full Text] [Related]
3. Cyclooxygenase-2 in myocardium stimulation by angiotensin-II in cultured cardiac fibroblasts and role at acute myocardial infarction.
Scheuren N; Jacobs M; Ertl G; Schorb W
J Mol Cell Cardiol; 2002 Jan; 34(1):29-37. PubMed ID: 11812162
[TBL] [Abstract][Full Text] [Related]
4. Involvement of cyclooxygenase-derived prostaglandin E2 and nitric oxide in the protection of rat pancreas afforded by low dose of lipopolysaccharide.
Jaworek J; Bonior J; Tomaszewska R; Jachimczak B; Kot M; Bielański W; Pawlik WW; Sendur R; Stachura J; Konturek PC; Konturek SJ
J Physiol Pharmacol; 2001 Mar; 52(1):107-26. PubMed ID: 11321505
[TBL] [Abstract][Full Text] [Related]
5. Classic NSAID and selective cyclooxygenase (COX)-1 and COX-2 inhibitors in healing of chronic gastric ulcers.
Brzozowski T; Konturek PC; Konturek SJ; Sliwowski Z; Pajdo R; Drozdowicz D; Ptak A; Hahn EG
Microsc Res Tech; 2001 Jun; 53(5):343-53. PubMed ID: 11376495
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of COX pathway in experimental myocardial infarction.
Saito T; Rodger IW; Hu F; Robinson R; Huynh T; Giaid A
J Mol Cell Cardiol; 2004 Jul; 37(1):71-7. PubMed ID: 15242737
[TBL] [Abstract][Full Text] [Related]
7. Cyclooxygenase-2 inhibition increases mortality, enhances left ventricular remodeling, and impairs systolic function after myocardial infarction in the pig.
Timmers L; Sluijter JP; Verlaan CW; Steendijk P; Cramer MJ; Emons M; Strijder C; Gründeman PF; Sze SK; Hua L; Piek JJ; Borst C; Pasterkamp G; de Kleijn DP
Circulation; 2007 Jan; 115(3):326-32. PubMed ID: 17210840
[TBL] [Abstract][Full Text] [Related]
8. Prostaglandin E2 inhibits transforming growth factor beta 1-mediated induction of collagen alpha 1(I) in hepatic stellate cells.
Hui AY; Dannenberg AJ; Sung JJ; Subbaramaiah K; Du B; Olinga P; Friedman SL
J Hepatol; 2004 Aug; 41(2):251-8. PubMed ID: 15288474
[TBL] [Abstract][Full Text] [Related]
9. Phorbol ester stimulates cyclooxygenase-2 expression and prostanoid production in cardiac myocytes.
Schuette R; LaPointe MC
Am J Physiol Heart Circ Physiol; 2000 Aug; 279(2):H719-25. PubMed ID: 10924071
[TBL] [Abstract][Full Text] [Related]
10. Involvement of cyclooxygenase (COX)-2 products in acceleration of ulcer healing by gastrin and hepatocyte growth factor.
Brzozowski T; Konturek PC; Konturek SJ; Pajdo R; Schuppan D; Drozdowicz D; Ptak A; Pawlik M; Nakamura T; Hahn EG
J Physiol Pharmacol; 2000 Dec; 51(4 Pt 1):751-73. PubMed ID: 11192947
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of cyclooxygenase-2 improves cardiac function in myocardial infarction.
Saito T; Rodger IW; Hu F; Shennib H; Giaid A
Biochem Biophys Res Commun; 2000 Jul; 273(2):772-5. PubMed ID: 10873679
[TBL] [Abstract][Full Text] [Related]
12. Up-regulation of cyclooxygenase-2 by inhibition of cyclooxygenase-1: a key to nonsteroidal anti-inflammatory drug-induced intestinal damage.
Tanaka A; Hase S; Miyazawa T; Takeuchi K
J Pharmacol Exp Ther; 2002 Mar; 300(3):754-61. PubMed ID: 11861778
[TBL] [Abstract][Full Text] [Related]
13. Role of constitutive cyclooxygenase-2 in prostaglandin-dependent secretion in mouse colon in vitro.
MacNaughton WK; Cushing K
J Pharmacol Exp Ther; 2000 May; 293(2):539-44. PubMed ID: 10773026
[TBL] [Abstract][Full Text] [Related]
14. Both cyclooxygenase-1 and cyclooxygenase-2 mediate osteoblast response to titanium surface roughness.
Boyan BD; Lohmann CH; Sisk M; Liu Y; Sylvia VL; Cochran DL; Dean DD; Schwartz Z
J Biomed Mater Res; 2001 Jun; 55(3):350-9. PubMed ID: 11255188
[TBL] [Abstract][Full Text] [Related]
15. Dose-dependent modulation of apoptosis and cyclooxygenase-2 expression in human 1547 osteosarcoma cells by NS-398, a selective cyclooxygenase-2 inhibitor.
Moalic S; Liagre B; Le Bail JC; Beneytout JL
Int J Oncol; 2001 Mar; 18(3):533-40. PubMed ID: 11179483
[TBL] [Abstract][Full Text] [Related]
16. Cyclooxygenase-2-mediated regulation of Kupffer cell interleukin-6 production following trauma-hemorrhage and subsequent sepsis.
Knöferl MW; Diodato MD; Schwacha MG; Cioffi WG; Bland KI; Chaudry IH
Shock; 2001 Dec; 16(6):479-83. PubMed ID: 11770048
[TBL] [Abstract][Full Text] [Related]
17. Cyclooxygenase-1 mediates the final stage of morphine-induced delayed cardioprotection in concert with cyclooxygenase-2.
Jiang X; Shi E; Nakajima Y; Sato S; Ohno K; Yue H
J Am Coll Cardiol; 2005 May; 45(10):1707-15. PubMed ID: 15893191
[TBL] [Abstract][Full Text] [Related]
18. Exaggerated left ventricular dilation and reduced collagen deposition after myocardial infarction in mice lacking osteopontin.
Trueblood NA; Xie Z; Communal C; Sam F; Ngoy S; Liaw L; Jenkins AW; Wang J; Sawyer DB; Bing OH; Apstein CS; Colucci WS; Singh K
Circ Res; 2001 May; 88(10):1080-7. PubMed ID: 11375279
[TBL] [Abstract][Full Text] [Related]
19. Cyclooxygenase-2 mediates the cardioprotective effects of the late phase of ischemic preconditioning in conscious rabbits.
Shinmura K; Tang XL; Wang Y; Xuan YT; Liu SQ; Takano H; Bhatnagar A; Bolli R
Proc Natl Acad Sci U S A; 2000 Aug; 97(18):10197-202. PubMed ID: 10963682
[TBL] [Abstract][Full Text] [Related]
20. Inhibited proliferation of cyclooxygenase-2 expressing human hepatoma cells by NS-398, a selective COX-2 inhibitor.
Hu KQ; Yu CH; Mineyama Y; McCracken JD; Hillebrand DJ; Hasan M
Int J Oncol; 2003 Apr; 22(4):757-63. PubMed ID: 12632065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
